Drug Delivery Systems

Oral film to treat acute migraines to be launched across the US after FDA approval

18-Apr-2023 By Liza Laws

A drug to treat acute migraines has been given approval for a new drug application (NDA) by the US Food and Drug Administration (FDA).

Cingulate and Indegene announce agreement for lead ADHD drug - the first of its kind

31-Mar-2023 By Liza Laws

An agreement has been reached to promote Cingulate Inc’s ‘first true entire active day medication’ designed to treat attention deficit hyperactivity disorder (ADHD).

Sai Life Sciences opens UK lab for drug substance and intermediates

23-Mar-2023 By Ben Hargreaves

The Indian company announces that it has set up a GMP kilo lab at its existing facility in Manchester, UK.

Phillips-Medisize launches disposable pen injector

09-Feb-2023 By Ben Hargreaves

The company announces an addition to its portfolio of drug delivery devices, with its pen injector platform that is described as being more affordable to produce.

Aptar announces ‘highly recyclable’ nasal spray

06-Feb-2023 By Ben Hargreaves

The company outlines that has designed a nasal spray pump that uses no metal parts to deliver OTC formulations.

Biogen licenses subcutaneous drug delivery system for neurological drugs

12-Jan-2023 By Ben Hargreaves

Biogen partners with Alcyone to gain access to ThecaFlex, which is able to deliver therapies into the intrathecal space.

Precision delivery device offers hope for menstrual migraine patients

08-Sep-2022 By Jenni Spinner

Impel Pharmaceuticals’ Trudhesa treatment, paired with its Precision Olfactory Delivery system, reportedly shows promise to women suffering from the condition.

Celanese lands Gates Foundation grant for refillable contraceptive research

29-Aug-2022 By Jenni Spinner

The company has landed funding from the Bill and Melinda Gates Foundation for research and development on a prototype of a refillable contraceptive solution.

Impel Pharmaceuticals reports progress with ASD-related drug trial

29-Aug-2022 By Jenni Spinner

The company reports dosing of the first subject in a Phase IIa proof-of-concept study investigating a drug for an autism spectrum disorder related condition.

Impel Pharmaceuticals upper-nasal delivery offers hope for migraine patients

26-Apr-2022 By Jenni Spinner

The company’s Precision Olfactory Delivery technology, currently combined with its Trudhesa migraine treatment, reportedly facilitates high absorption rates.

CPhI Worldwide

Gerresheimer develops delivery device for drugs with higher viscosity

03-Nov-2021 By Jane Byrne

CPhI Worldwide will see Gerresheimer showcase its latest developments in primary packaging, drug delivery systems for newly developed biologics along with medical and diagnostic products.

US pharma market ahead of Europe on drug device innovation: Pharmapack

21-Sep-2021 By Jenni Spinner

A report from the industry event’s organizers indicates American companies have an edge on drug delivery innovation but lag in operational sustainability.

CPhI Festival of Pharma

Noble to address drug delivery evolution at CPhI

30-Sep-2020 By Jenni Spinner

A leader from the pharma solutions firm will discuss the future of drug delivery at a keynote during the CPhI Festival of Pharma virtual event.

SHL buyout looks to advance self-injection drug delivery offering

31-Mar-2020 By Vassia Barba

With the acquisition of Weibel, SHL Medical looks to the development of novel drug delivery systems for self-administration, answering a need for improved patient-centricity in the sector.

Patient confidence key in switching delivery of biosimilars

05-Feb-2020 By Ben Hargreaves

As developers of biosimilars look at ways of differentiating from originator products, experts warn that patients will need to be brought on board.

3M set to sell biopharma-focused CDMO for $650m

23-Dec-2019 By Nick Taylor

3M agrees to sell drug delivery contract service unit to investment group Altaris Capital Partners.

LEO partners for needle-free delivery of biologics

05-Dec-2019 By Ben Hargreaves

LEO and Portal collaborate in the development of needle-free device to allow patient to self-administer dermatology products.

CPhI Worldwide 2019

Integrating the patient’s voice into drug delivery systems

13-Nov-2019 By Vassia Barba

While exhibiting its offering in self-administration devices at the CPhI Worldwide event in Frankfurt last week, West told us how patient convenience drives design and development.

Genentech to advance on-body drug delivery platform

26-Aug-2019 By Maggie Lynch

Genentech enters a manufacturing and development agreement with Enable Injections to advance the latter’s patient-administered subcutaneous drug delivery system.

Topical drug delivery market to reach $123bn by 2024

21-Aug-2019 By Vassia Barba

High prevalence of skin disease and diabetes to boost the global revenues of the topical drug delivery market, with uptake in China and India boosting growth.

Tiny bottles create controlled release system to deliver chemo

20-Aug-2019 By Maggie Lynch

Nanoscale silica bottles, a five-hundredth of the diameter of a hair, could be used to deliver cancer drugs to specific disease sites in the body, avoiding debilitating side effects.

Activated carbon ‘acts like a slow-release drug capsule’ in drug delivery study

19-Aug-2019 By Maggie Lynch

Researchers at the University of Illinois at Chicago reported that combining activated charcoal with herpes treatment acyclovir, improves the drug’s efficacy.

Croda plans life science investment after big quarter for excipient unit

06-Aug-2019 By Nick Taylor

Croda plans investments in life science business after high-purity excipient delivery system business drives 24% jump in healthcare sales.

Narcan-like drug delivery system approved for emergency treatment

05-Aug-2019 By Maggie Lynch

Aptar’s needle-free, emergency powder formulation treatment for patients with diabetes and severe hypoglycemia is the company’s first combination drug delivery device with active packaging.

Acquisition of two treatments ‘rounds out’ Upsher-Smiths migraine portfolio

01-Aug-2019 By Maggie Lynch

The acquisition of two migraine therapies from Dr Reddy’s has been completed by Upsher-Smith, adding different drug delivery treatment options to its migraine product portfolio.

Boehringer acquires ICD to ease biologic delivery

15-Apr-2019 By Maggie Lynch

Boehringer acquires rights to ICD Therapeutics and its biologics-delivery platform for the development of oncology and immune oncology compounds.

Adlon’s ADHD treatment approved but with black box warning

11-Mar-2019 By Maggie Lynch

Adlon announces FDA approval of its extended-release ADHD medication.

Genentech taps Halozyme’s tech in Herceptin Hylecta

05-Mar-2019 By Maggie Lynch

Genentech receives US FDA approval on Herceptin Hylecta, a subcutaneous co-formulation using Halozyme’s recombinant Enhanze technology, for the treatment of HER2-positive metastatic breast cancer.

Round-up: Innovations and developments in drug delivery

26-Feb-2019 By Maggie Lynch

Innovations in drug delivery have hit the market running and as complex drugs breaking onto the market while delivery systems and technologies follow.

Drug delivery manufacturing evolves to keep up with intricate therapies

26-Feb-2019 By Maggie Lynch

A drug is only as effective as its delivery system, and the advent of new molecules and new innovations have to be matched by enhanced delivery and containment methods, suggests West Pharma exec.

Haselmeier manufacture disposable injection device after receiving allowance

25-Feb-2019 By Maggie Lynch

Haselmeier to provide assembly, labeling, and packaging services for its drug-device combination products following recent permission given to Germany-site.

US FDA to publish additional guidance to ‘genericize’ complex drugs

05-Feb-2019 By Maggie Lynch

As complex drugs see little competition, the FDA will distribute guidelines to increase approvals of generic medicines for ‘economic stability’ and to bring affordable drugs to patients.

Complex transdermal generic drug receives approval, enters market

22-Jan-2019 By Maggie Lynch

Amneal received approval of a generic of the Exelon patch, a complex generic transdermal drug delivery system, and plans to commercialize the product.

AZ signs agreement for targeted drug delivery research

14-Jan-2019 By Maggie Lynch

AstraZeneca and Aptamer Group will collaborate to leverage Aptamer’s platform for targeted delivery of oligonucelotides to the kidney for therapeutic development.

AAPS PharmSci 360: Quotes that carry

09-Nov-2018 By Maggie Lynch

This week in-PharmaTechnologist attended AAPS PharmSci360 in Washington, D.C. where discussions and thought-provoking ideas bounced across sessions – here, we highlight some of the most significant.

Hikma latest to ink long-term prefilled deal with 'ambitious' Unilife

26-Nov-2013 By Dan Stanton

Unilife has signed a $40m long-term supply agreement with Hikma and says it is committed to becoming the world’s largest and most successful injectable drug delivery systems supplier.

Cargill: Pharma Increases Interest in Seaweed-Derived Excipients

12-Sep-2013 By Dan Stanton

Cargill says interest from the pharma industry for its seaweed-derived excipient is growing as it invests $15m (€11.3m) into its French alginate production plant.

Appointments from Unilife, Aceto and Cangene – People on the move

18-Aug-2011 By Natalie Morrison

in-PharmaTechnologist.com presents its round-up of executive moves within the pharma sector, including appointments from Unilife, Aceto and Cangene.

Gerresheimer expands Indian presence with Mumbai office

10-Nov-2010 By Alexandria Pesic

Gerresheimer will open a representative office in Mumbai India this week as part of its growth strategy to capitalise in emerging markets.

Drug delivery round-up: News in brief

14-Oct-2008 By Nick Taylor

in-PharmaTechnologist.com presents its latest round up of developments in drug delivery, including Philips first foray into drug delivery and a licensing deal for 3M.

A world of outsourcing awaits - part III drug manufacturing

25-Oct-2006 By Kirsty Barnes

Although manufacturing is the most established of the pharma
outsourcing segments, many service areas are still rapidly
evolving. OutsourcingPharma.com gives a brief run down of the
current state of play.

Application scope reveals Nanotechnology potential

27-Apr-2005

According to a new report, nanotechnology is set to play a major
part in drug delivery systems especially for tumour therapies. The
report cites nanoparticles as being particularly suited to curing
specific conditions such as cancer,...